Patent · US Active

Rhinovirus vaccines

US8153760B2 · kind B2 · utility

3Cited by
1References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 17, 2006
Grant dateApr 10, 2012
Priority date
Expiry dateFeb 8, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/32734
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates generally to peptide vaccines. More specifically, the present invention relates to vaccines against rhinoviruses and other related and non-related pathogenic animal viruses. In addition, the present invention relates generally to methods of designing and producing vaccines against viruses and, in certain embodiments, against rhinoviruses and other pathogenic viruses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.